JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7671 (±)-AMG 487

Summary: CXCR3 antagonist

<60.36 mg/mL
B7696 GW 627368

Summary: prostanoid EP4 receptor antagonist

≥48 mg/mL
B7748 DBM 1285 dihydrochloride

Summary: p38 MAPK inhibitor

<46.84 mg/mL
A8194 ABT-199

36 Citation

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and selective

≥43.42 mg/mL
A4092 CUDC-101

1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A4143 CYT387

1 Citation

Summary: JAK-1/-2 inhibitor,ATP competitive

insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
A4101 Tubastatin A

11 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A4125 CYC116

Target: Aurora Kinases|FLT3|VEGFR

Summary: Potent Aurora A/B inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
A4343 Dyphylline

Summary: Pan-PDE inhibitor

≥17.17 mg/mL
A8163 AM 114

2 Citation

Target: Proteasome

Summary: 20S proteasome inhibitor

insoluble in H2O; ≥16.65 mg/mL